Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliation: Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland (firstname.lastname@example.org).
To the Editor: Dr Monson and colleagues1 conducted a randomized controlled trial of cognitive-behavioral conjoint therapy delivered to patients for posttraumatic stress disorder (PTSD) and their significant others compared with a wait-list control group. However, whether the difference between the groups is due to a benefit of cognitive-behavioral conjoint therapy or a harm of waiting on a list is not clear.
Prasad V. Couple Therapy for Posttraumatic Stress Disorder. JAMA. 2012;308(23):2458. doi:10.1001/jama.2012.14558